Thousands of cases of amputation and vision loss could be prevented thanks to diabetes monitoring technology.
Continuous Glucose Monitors, or CGMs, have been funded for Type 1 diabetes since last October.
New data from CGM producer Dexcom finds lifetime use of the devices could prevent up to 70 thousand diabetes-related complications and save the country $50 thousand a day.
Diabetes New Zealand Chief Executive Heather Verry told Mike Hosking funding should be expanded to all diabetes patients.
She says Pharmac is only funding for Type 1, and at $200 a month, these devices are unaffordable for everyone else.
LISTEN ABOVE

Mark Smith: ASB Chief Economist on their expectation GDP will grow 0.3% in the June quarter despite the Middle East war
02:11

Mike's Minute: AI isn't going to wipe us out
02:23

Pollies: National's Mark Mitchell and Labour's Ginny Andersen on the Tom Phillips inquiry, public meetings
09:49